Bourne Partners Revenue and Competitors

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • Bourne Partners's estimated annual revenue is currently $8.1M per year.(i)
  • Bourne Partners's estimated revenue per employee is $140,000

Employee Data

  • Bourne Partners has 58 Employees.(i)
  • Bourne Partners grew their employee count by 57% last year.

Bourne Partners's People

NameTitleEmail/Phone
1
CEO and Senior Managing DirectorReveal Email/Phone
2
Chief Operating Officer and General CounselReveal Email/Phone
3
Chief StaffReveal Email/Phone
4
Head ResearchReveal Email/Phone
5
Investment Banking VPReveal Email/Phone
6
Investment Banking VPReveal Email/Phone
7
DirectorReveal Email/Phone
8
Managing DirectorReveal Email/Phone
9
Managing Director and Head Healthcare ServicesReveal Email/Phone
10
Director Legal AffairsReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$15M7127%N/AN/A
#2
$15M20-20%N/AN/A
#3
$7.5M2238%N/AN/A
#4
$8.1M5857%N/AN/A
#5
$15M5146%N/AN/A
Add Company

What Is Bourne Partners?

Bourne Partners is a financial services firm specializing in the pharma, pharma services, and consumer health sectors. Located in Charlotte, North Carolina, the company offers investment banking and advisory services, as well as direct investment opportunities. As owners and operators with over 20 years of experience, Bourne Partners strives to enrich the lives and improve the health and well-being of their partners and patients across the globe by facilitating the efficient movement of capital through the global healthcare sector.\n\nBourne Partners currently operates two distinct business segments, which enjoy valuable synergies. \n\nBourne Partners Investment Banking\nBourne Partners Investment Banking division provides investment banking services within the healthcare and life sciences sector for both external clients as well as our portfolio companies. Bourne Partners has worked alongside some of the leading strategic and Private Equity companies including Cerberus, Cinven, Irving Place Capital and The Carlyle Group. Specialties include mergers and acquisitions, sell and buy-side transactions, licensing and partnering opportunities, equity and debt capital, and strategic consulting.\n\nBourne Partners Strategic Capital \nBourne Partners Strategic Capital partners with and invests in pharmaceutical and pharmaceutical services companies and management teams where we can add long term strategic value. Select investments include AMRI, Covis Pharma S.à.r.l., iNova Pharmaceuticals, Millicent Pharma, King Pharmaceuticals, Novitium Pharma, and WelldyneRx among others.

keywords:N/A

N/A

Total Funding

58

Number of Employees

$8.1M

Revenue (est)

57%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.3M585%N/A
#2
$9.4M584%N/A
#3
$15.1M5816%N/A
#4
$9.4M5812%N/A
#5
$20.9M584%N/A